Antiretroviral therapy for prevention of HIV infection: New clues from an animal model
2008

Preventing HIV Transmission in Macaques with Antiretroviral Therapy

Sample size: 18 publication Evidence: moderate

Author Information

Author(s): Myron S. Cohen, Angela D. M. Kashuba

Primary Institution: University of North Carolina at Chapel Hill

Hypothesis

Can antiretroviral pre-exposure prophylaxis regimens effectively prevent HIV transmission in macaques?

Conclusion

The study found that certain antiretroviral regimens provided complete protection against HIV infection in macaques.

Supporting Evidence

  • Four out of six macaques became infected with FTC alone.
  • Two out of six macaques became infected with a combination of FTC and TDF.
  • None of the twelve macaques receiving a specific dosing regimen became infected.

Takeaway

Researchers tested different medicines to see if they could stop monkeys from getting a virus similar to HIV, and some combinations worked really well.

Methodology

Macaques were exposed to weekly rectal virus challenges for up to 14 weeks while receiving various antiretroviral PrEP regimens.

Potential Biases

The use of historical controls may introduce bias in the results.

Limitations

The study had small sample sizes, used historical controls, and the drug doses were higher than those typically seen in humans.

Participant Demographics

Macaques were used as the study subjects.

Digital Object Identifier (DOI)

10.1371/journal.pmed.0050030

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication